HCAT vs TXG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

HCAT

44.4
AI Score
VS
HCAT Wins

TXG

33.6
AI Score

Investment Advisor Scores

HCAT

44score
Recommendation
HOLD

TXG

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT TXG Winner
Forward P/E 10 1250 HCAT
PEG Ratio 0 0 Tie
Revenue Growth -12.7% -12.7% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.4/100 33.6/100 HCAT
Profit Margin -90.6% -12.2% TXG
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

HCAT 1M: -0.6% · 3M: -18.3% TXG 1M: +48.0% · 3M: +127.5%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.4 · Price: $1.70

TXG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (28.4% over 20 days), RSI 73

RSI (14): 73.4 · Price: $88.76

Fundamentals Snapshot

Metric HCAT TXG
Market Cap — —
Forward P/E 226.7 1157.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% -0.1%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% -0.2%
EPS -3.73 -0.60
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.